美股市場個股詳情
TEVA 梯瓦製藥
- 13.770
- -0.280-1.99%
交易中 05/01 12:37 (美東)
155.96億總市值-27540市盈率TTM
14.040最高價13.700最低價333.67萬股成交量13.980今開14.050昨收4608.27萬成交額0.30%換手率虧損市盈率(靜)11.33億總股本14.46552周最高2.08市淨率155.03億流通值7.08552周最低--股息TTM11.26億流通股68.007歷史最高--股息率TTM2.42%振幅3.107歷史最低13.810平均價1股每手
梯瓦製藥股票討論區
登錄發表評論
UPDATE May 1
MAYDAY!!!
🤣 hahaha, my favorite gif 🤣
🎵 Here's where the story ends
It's that little souvenir of a terrible year
Which makes my eyes feel sore
It's that little souvenir of a terrible year
Surprise, surprise, surprise 🎵
I'm going to try and get a post out. I'm really uncomfortable and sore, but there are some big moves and big news ahead.
A little Sundays to start the day
As I said, I'm fresh out of the hospital again. I've been oversleeping and much too tired 😫. I feel gu...
🤣 hahaha, my favorite gif 🤣
🎵 Here's where the story ends
It's that little souvenir of a terrible year
Which makes my eyes feel sore
It's that little souvenir of a terrible year
Surprise, surprise, surprise 🎵
I'm going to try and get a post out. I'm really uncomfortable and sore, but there are some big moves and big news ahead.
A little Sundays to start the day
As I said, I'm fresh out of the hospital again. I've been oversleeping and much too tired 😫. I feel gu...
加載中...
9
3
$梯瓦製藥(TEVA.US$ & alvotechpr
📣 FDA approves SELARSDI (Ustekinumab-Aekn), biosimilar to Stelara® 🎉
▻ approved for both adult and pedia indications (plaque psoriasis & psoriatic arthritis)
▻ developed and manuf. using same type of cells and process used for Stelara 👨🔬
▻ to be marketed in US on or after 02/21/25 🗓️
📣 FDA approves SELARSDI (Ustekinumab-Aekn), biosimilar to Stelara® 🎉
▻ approved for both adult and pedia indications (plaque psoriasis & psoriatic arthritis)
▻ developed and manuf. using same type of cells and process used for Stelara 👨🔬
▻ to be marketed in US on or after 02/21/25 🗓️
3
1
$梯瓦製藥(TEVA.US$ Pray Kwan Yin bless teva
The analyst from J.P. Morgan expressed that Teva has effectively addressed concerns about the investments required to develop these assets preserving margins through strategic partnerships.
Teva's divestment of its API division is in line with its strategy to focus on branded medicines and slim down its generic medicine business. This move will enable Teva to concentrate its capital on driving the Pivot to Growth strategy, mainly around its innovative and generics portfolio.
The P/S ratio for Teva Pharmaceutical Industries indicates expected limited growth, as mirrored in investors’ reduced payout. This viewpoint might endure unless revenue prospects improve.
1
WHY I AM BUYING RDHL....BUY HAND OVER FIST
$Redhill Biopharma(RDHL.US$
As we're all aware, TEVA stands out as one of the premier generic labs in Israel, with even Warren Buffett having previously held a significant stake in its shares. As we gradually divest from TEVA throughout our portfolio, RDHL emerges as a substantial opportunity to allocate current funds for potential future gains. Personally, I've been acquiring shares extensively, and in my view, RDHL appears to be a potential blockbuste...
As we're all aware, TEVA stands out as one of the premier generic labs in Israel, with even Warren Buffett having previously held a significant stake in its shares. As we gradually divest from TEVA throughout our portfolio, RDHL emerges as a substantial opportunity to allocate current funds for potential future gains. Personally, I've been acquiring shares extensively, and in my view, RDHL appears to be a potential blockbuste...
暫無評論
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅
Mod Tan : 感謝分享
TinkerB3ll : 謝謝 @iamiam 查看廣泛的列表，想知道您對 MSOS 是什麼想法？
iamiam樓主 TinkerB3ll: 我更喜歡有個別公司。MSOS 是一款 Blackrock 創作，它們有很多交換和衍生品，他們甚至有債券
如果你持有它也不錯。這不是我的東西。我的喜好太多交換和衍生工具。